Company: VREOF
Filing Date: 2025-12-09
Form Type: S-3
Source: 0001104659-25-119699
Chunk: 42

Company: Vireo Growth Inc.
Filing Date: 2025-12-09
Form: S-3
Chunk 42
---
 Paul Roos and Blue Owl GP Stakes II (A), LP, a non-voting member, and such individuals and entity disclaim beneficial ownership of the securities held by the Fund, except to the extent of such individual or entity’s pecuniary interest therein, if any. The business address of WBA and the Fund is 3033 Excelsior Blvd., Suite 500, Minneapolis, Minnesota 55416. |

| (5) | Whitebox Advisers LLC (“WBA”) is the investment manager of Pandora Select Partners, LP (the “Fund”) and has voting and disposition control over the securities beneficially owned by the Fund. WBA is owned by the following members: Robert Vogel, Jacob Mercer, Nick Stukas, Brian Lutz, Paul Roos and Blue Owl GP Stakes II (A), LP, a non-voting member, and such individuals and entity disclaim beneficial ownership of the securities held by the Fund, except to the extent of such individual or entity’s pecuniary interest therein, if any. The business address of WBA and the Fund  is 3033 Excelsior Blvd., Suite 500, Minneapolis, Minnesota 55416. |

| (6) | Whitebox Advisers LLC (“WBA”) is the investment manager of Whitebox GT Fund, LP (the “Fund”) and has voting and disposition control over the securities beneficially owned by the Fund. WBA is owned by the following members: Robert Vogel, Jacob Mercer, Nick Stukas, Brian Lutz, Paul Roos and Blue Owl GP Stakes II (A), LP, a non-voting member, and such individuals and entity disclaim beneficial ownership of the securities held by the Fund, except to the extent of such individual or entity’s pecuniary interest therein, if any. The business address of WBA and the Fund  is 3033 Excelsior Blvd., Suite 500, Minneapolis, Minnesota 55416. |

| (7) | Reflects 31,184,874 Subordinate Voting Shares acquired by FarmaceuticalRX LLC in the equity raise                           
 completed by the Company in December 2024 on a private placement basis and 16,465,097 Subordinate Voting Shares received as 
 consideration in connection with the Note Purchase Agreements. Siham                                                        
 Bouziane Tigoudar has sole voting and dispositive power over the securities held by FarmaceuticalRX LLC.                    |

| (8) | Michael W. Miller has sole voting and